Endo International | ENDP - Action



Action Changement Date
AbbVie USD 4.95B 13M 2025-12
Amarin USD 184.7M 13.46M 2025-09
ANI Pharmaceuticals USD 143.07M 3.41M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
Hikma Pharmaceutical USD 1.08B 96M 2025-06
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
Merck USD 6.44B 157M 2025-09
Novartis USD 6.42B 114M 2025-09
Pacira USD 152.86M 4.82M 2025-12
Perrigo USD 1.15B 78M 2025-12
Pfizer USD 11.47B 201M 2025-09
Phibro Animal Health USD 517.35M 45.57M 2025-12
Supernus Pharmaceuticals USD 107.1M 63.08M 2025-09
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Xeris Pharmaceuticals USD 68.67M 1.21M 2025-12
Zoetis USD 2.43B 35M 2025-12